The Leonberger is a large, calm, and loving breed cherished by many dog lovers across the United States, though it remains relatively rare. Alongside their wonderful temperament, these gentle giants face some genetic health issues, including serious neurological disorders that can deeply affect a dog's mobility and life quality.
To better safeguard Leonberger health, the American Kennel Club and associated breeding organizations are now supporting new DNA testing protocols designed to identify genetic markers for two major disorders: Leonberger polyneuropathy type 2 (LPN2) and leukoencephalomyelopathy (LEMP). These tests complement the existing LPN1 DNA screening, offering breeders a more extensive genetic profile to make responsible mating decisions.
Leonberger polyneuropathy is a hereditary nerve and muscle disease that usually shows up in young dogs. The LPN2 mutation causes progressive weakening in muscles, especially in the hind legs, leading to difficulties with walking, reduced stamina, and sometimes even breathing problems. The previously known LPN1 form also contributes to these symptoms and has been tested by breeders for some years now.
LEMP is another inherited neurodegenerative disorder in Leonbergers, marked by symptoms similar to polyneuropathy but without associated pain. This disease detrimentally impacts mobility and overall wellbeing. LEMP stems from a different genetic mutation than the polyneuropathy types, necessitating its own specific DNA test.
The updated genetic screenings involve a simple cheek swab collected by your veterinarian, which is then sent to authorized laboratories recognized by the AKC or breed health foundations. Results commonly return within one to three weeks, enabling breeders to determine whether a dog carries mutations related to LPN2 and LEMP.
It is important to know that while a test negative for LPN2 markers lowers risk, it doesn’t guarantee a dog will be free from the condition, as scientific understanding of its genetics remains incomplete. In contrast, the LEMP test is strongly linked to a known mutation; however, not every dog with this mutation will exhibit clinical symptoms, indicating other factors contribute to its manifestation.
DNA test findings provide valuable insights to help breeders avoid pairing dogs that would likely pass on debilitating conditions, thereby promoting the breed's lasting health and vitality. For example:
If you own a Leonberger or plan to breed, consult your veterinarian about obtaining DNA testing. This quick and non-invasive procedure reveals important genetic health information and supports breeding decisions that preserve the breed's wellbeing for future generations. Sharing results with breed clubs and registries in the U.S. adds confidence for those searching for Leonberger puppies.
| Test | Condition | Accuracy/Notes | Breeding Recommendations |
|---|---|---|---|
| LPN1 | Polyneuropathy Type 1 | High reliability; causative mutation identified | Avoid breeding affected dogs; prioritize clear (N/N) dogs |
| LPN2 | Polyneuropathy Type 2 | Moderate reliability; genetics partly understood | Exercise caution; mate carriers only with clear dogs |
| LEMP | Leukoencephalomyelopathy | Strong genetic link; incomplete disease expression | Avoid breeding affected dogs; test offspring |
No genetic test can guarantee absolute certainty, but these screenings are vital tools helping to minimize the occurrence of inherited, debilitating diseases in Leonbergers. They empower breeders to take responsible steps, focusing on the health and longevity of this beloved giant breed.
In the United States, organizations such as the Leonberger Health Foundation International and veterinary genetics labs at universities like the University of Minnesota actively support these testing programs. Given concerns about reduced genetic diversity and inbreeding within the North American Leonberger population, DNA testing combined with prudent breeding strategies is essential to sustaining the breed’s future.